Literature DB >> 9305864

Direct inhibition of mitochondrial respiratory chain complex III by cell-permeable ceramide.

T I Gudz1, K Y Tserng, C L Hoppel.   

Abstract

Ceramide is a lipid second messenger that mediates the effects of tumor necrosis factor alpha and other agents on cell growth and differentiation. Ceramide is believed to act via activation of protein phosphatase, proline-directed protein kinase, or protein kinase C. Tumor necrosis factor alpha-induced common pathway of apoptosis is associated with an early impairment of mitochondria. Herein, we demonstrate that ceramide can directly inhibit mitochondrial respiratory chain function. In isolated mitochondria, a rapid decline of mitochondrial oxidative phosphorylation occurs in the presence of N-acetylsphingosine (C2-ceramide), a synthetic cell-permeable ceramide analog. An investigation of the site of ceramide action revealed that the activity of respiratory chain complex III is reduced by C2-ceramide with half-maximum effect at 5-7 microM. In contrast, N-acetylsphinganine (C2-dihydroceramide), which lacks a functionally critical double bond and is ineffective in cells, did not alter mitochondrial respiration or complex III activity. We suggest that these in vitro observations may set the stage for identifying a novel mechanism of regulation of mitochondrial function in vivo.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9305864     DOI: 10.1074/jbc.272.39.24154

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  132 in total

Review 1.  Heart mitochondria signaling pathways: appraisal of an emerging field.

Authors:  José Marín-García; Michael J Goldenthal
Journal:  J Mol Med (Berl)       Date:  2004-06-23       Impact factor: 4.599

Review 2.  A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome.

Authors:  Gerwyn Morris; Michael Maes
Journal:  Metab Brain Dis       Date:  2012-06-21       Impact factor: 3.584

3.  A mitochondrial pool of sphingomyelin is involved in TNFalpha-induced Bax translocation to mitochondria.

Authors:  Helene Birbes; Chiara Luberto; Yi-Te Hsu; Samer El Bawab; Yusuf A Hannun; Lina M Obeid
Journal:  Biochem J       Date:  2005-03-15       Impact factor: 3.857

4.  Apoptosis induction by interleukin-2-activated cytotoxic lymphocytes in a squamous cell carcinoma cell line and Daudi cells - involvement of reactive oxygen species-dependent cytochrome c and reactive oxygen species-independent apoptosis-inducing factors.

Authors:  Tetsuya Yamamoto; Eisaku Ueta; Tokio Osaki
Journal:  Immunology       Date:  2003-10       Impact factor: 7.397

Review 5.  The role of ceramides in metabolic disorders: when size and localization matters.

Authors:  Sarah M Turpin-Nolan; Jens C Brüning
Journal:  Nat Rev Endocrinol       Date:  2020-02-14       Impact factor: 43.330

6.  Critical determinants of mitochondria-associated neutral sphingomyelinase (MA-nSMase) for mitochondrial localization.

Authors:  Vinodh Rajagopalan; Daniel Canals; Chiara Luberto; Justin Snider; Christina Voelkel-Johnson; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2014-12-04

7.  Exogenous and endogenous ceramides elicit volume-sensitive chloride current in ventricular myocytes.

Authors:  Frank J Raucci; Dayanjan S Wijesinghe; Charles E Chalfant; Clive M Baumgarten
Journal:  Cardiovasc Res       Date:  2009-12-14       Impact factor: 10.787

8.  Defective TNF-alpha-mediated hepatocellular apoptosis and liver damage in acidic sphingomyelinase knockout mice.

Authors:  Carmen García-Ruiz; Anna Colell; Montserrat Marí; Albert Morales; María Calvo; Carlos Enrich; José C Fernández-Checa
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

Review 9.  Sphingolipids, insulin resistance, and metabolic disease: new insights from in vivo manipulation of sphingolipid metabolism.

Authors:  William L Holland; Scott A Summers
Journal:  Endocr Rev       Date:  2008-05-01       Impact factor: 19.871

10.  Small-hairpin RNA and pharmacological targeting of neutral sphingomyelinase prevent diaphragm weakness in rats with heart failure and reduced ejection fraction.

Authors:  Philip D Coblentz; Bumsoo Ahn; Linda F Hayward; Jeung-Ki Yoo; Demetra D Christou; Leonardo F Ferreira
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-01-31       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.